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Objective: Human skin is a complex bilayered organ that serves as a protective barrier
against the environment. The loss of integrity of skin by traumatic experiences such as
burns and ulcers may result in considerable disability or ultimately death. Therefore,
in skin injuries, adequate dermal substitutes are among primary care targets, aimed at
replacing the structural and functional properties of native skin. To date, there are very
few single application tissue-engineered dermal constructs fulfilling this criterion. Silk
producedbythedomesticsilkworm,Bombyxmori,hasalonghistoryofuseinmedicine.
It has recently been increasingly investigated as a promising biomaterial for dermal
constructs.Silkcontains2fibrousproteins,sericinandfibroin.Eachoneexhibitsunique
mechanical and biological properties. Methods: Comprehensive review of randomized-
controlledtrialsinvestigatingcurrentdermalconstructsandthestructuresandproperties
ofsilk-basedconstructsonwoundhealing.Results:Thisreviewrevealedthatsilk-fibroin
is regarded as the most promising biomaterial, providing options for the construction of
tissue-engineered skin. Conclusion: The research available indicates that silk fibroin is
a suitable biomaterial scaffold for the provision of adequate dermal constructs.
Human skin is a complex organ made of 2 layers of dermis and epidermis. The loss of
the integrity of the protective barrier served by skin through injury or illness may result in
infection,dehydration,andnecrosis,whichmayultimatelyleadtoseveretraumaandshock,
with morbid consequences. Therefore, adequate cutaneous substitutes, which ideally, could
replace all the structures and functions of native skin are essential to permit maximal
recovery. Silk has recently been established as a biomaterial scaffold capable of fulfilling
the properties required for effective cutaneous constructs.
SKIN
Human skin anatomically and functionally consists of 2 primary layers:
1. The outer epidermis is composed of keratinized stratified squamous epithelium consist-
ing mainly of keratinocytes.
2. The dermis is a dense irregular connective tissue primarily consisting of fibroblasts,
which underlies and interdigitates with the epidermis.
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Figure 1. Normal human skin.
Underlying the dermis is the hypodermis (or subcutaneous layer), a loose connective
tissuecontainingvaryingamountsofadipocytes(Figure1).Themarginbetweenthedermis
and the hypodermis is abrupt; however, the 2 regions are structurally and functionally well
integrated through nerve and anatomizing vascular networks.
Skinhasadiverserangeoffunctions.Itservesasabarrieragainstmicroorganismsand
other environmental insults. It provides mechanical support against injury and radiation
such as ultraviolet light. Also, skin protects the body against dehydration and provides
sensory detection at the body surface.
CUTANEOUS CONSTRUCTS
Thedevelopmentofcutaneoussubstitutes/constructsbytissueengineering(TE)hasevolved
from simple cultured autologous epidermal sheets to more complex bilayered cutaneous
constructs (Figure 2). Currently, there are no tissue-engineered cutaneous constructs that
can duplicate the complexity of the human skin. Mainly, a dermal construct is created with
or without a temporary synthetic epidermis (Table 1).
CULTURED CUTANEOUS CONSTRUCTS
The attempts to create an effective skin substitute have been along the 3 TE approaches:
(1) gel approach, (2) scaffold approach, and (3) self-assembly approach. The scaffold ap-
proach is the most commonly used in TE (Figure 3). It is used to create porous scaffolds,
frequentlyfromnatural(eg,collagen)orbiosyntheticbiomaterialssuchaspolyglycolicacid
or polyvinyl alcohol. Classification of these scaffolds is based on the absence or presence
of cellular components, to either acellular or cellular respectively. Both systems have been
widely used in skin TE.
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Figure 2. The basic elements of tissue engineering.
Aninvivostudyofculturedartificialdermalsubstitutesshowedthatanartificialdermis
containing autologous cultured fibroblasts enhances the reepithelization of a full-thickness
skin defect when compared to an acellular dermal substitute scaffold.1 This emphasized the
significance of incorporating fibroblasts in all engineered constructs for skin replacement.
Therefore, cultured dermal substitutes can be prepared by the production of a scaffold for
thedermalcomponentandseedingitwithskinfibroblasts,capableofsecretingmanygrowth
factors as well as extracellular matrix (ECM) components to fill the gaps created by the
pores in the material.2–5 Subsequently, keratinocytes can be seeded upon the scaffold after
appropriate dermal maturation.
SILK: STRUCTURE AND PROPERTIES
Silks are well-known natural fibers produced by a variety of silkworm insects and spiders
including, Bombyx mori, which is one of the most widely studied sources.6 Silk fibers are
composed of 2 types of proteinous polymers (Figure 4):
1. Sericin, an antigenic gum-like protein that forms the outer rubbery hydrophilic coating,
and
2. Fibroin, the inner-core protein filaments consisting of hydrophobic amino acids, glycine
and alanine repeat sequences, which accounts for up to 90% of the total molecular
weight.7,8
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Table 1. Current cutaneous substitutes—divided into epidermal constructs, dermal constructs, and
complete bilayered (both epidermal and dermal) constructs
Type of construct Trade name Prominent cell type Layers
Epidermal construct LaserskinTM Keratinocytes Cultured autograft sheets
Dermal constructs AlloDermTM Acellular De-epithelialized cadaver dermis
IntegraTM Acellular 1. Silicone sheet
2. Collagen
3. Glycosaminoglycan
DermagraftTM Fibroblasts Polyglycolic acid or Poly(glactin)-910
scaffold seeded with neonatal
fibroblasts
TransCyteTM Fibroblasts 1. Silicone sheet
2. Nylon mesh
3. Collagen produced by neonatal
fibroblasts
Complete bilayered ApligrafTM Keratinocytes and 1. Allogeneic keratinocytes
constructs fibroblasts 2. Allogeneic fibroblasts
3. Bovine collagen gel
AcademiaTM Keratinocytes and 1. Allogeneic keratinocytes
fibroblasts 2. Allogeneic fibroblasts
3. Gylcosaminoglycan
4. Bovine collagen scaffold
OrCelTM Keratinocytes and 1. Allogeneic keratinocytes
fibroblasts 2. Allogeneic fibroblasts
3. Nonporous collagen gel
4. Bovine collagen scaffold
For decades, silk threads were used as surgical sutures until sensitization to sericin,
demonstrated by type I allergic responses (asthma and upregulated levels of IgEs), were re-
portedinpatients,undergoingrepeatedsurgicalprocedures.9–12 Therefore,sericin-removal
is an essential step before silks can be used clinically; thus recently, silk fibroin (SF) has
been increasingly investigated as a promising biomaterial for new biomedical applications.
Structurally, SF is characterized by heavy- and light-chain polypetides arranged into
highly organized β-sheet crystal regions through hydrogen bonding as well as semicrys-
talline regions that together are responsible for the elasticity and tensile strength.13–17 Fur-
thermore, silk fibers have greater elasticity than fibers of comparable tensile integrity18; for
example, the elasticity of dragline silk is 4 to 7 times higher than that of synthetic high-
tenacity fibers like Kevlar 49. In addition, silks are thermally stable up to approximately
∼250◦C, allowing processing over a vast range of temperatures.19
APPLICATION OF SF AS A BIOMATERIAL SCAFFOLD
Although silk has been used commercially for centuries, in textiles production and in many
clinical applications, only recently the use of solubilized SF has been explored as a bioma-
terial scaffold for cell culture and TE.20 The biomaterial scaffold/matrix plays a key role
in transducing environmental cues to cells seeded within it, acting in essence as a transla-
tor between the local environment and the developing tissue (neotissue), hence aiding the
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Figure 3. The scaffold approach to skin substitute production.
development of biologically viable functional tissue.18 The scaffold should essentially be
designed by mimicking the structure and function of native ECM proteins, which provide
mechanical support and regulate cell activities.21
It should support cell attachment and migration as well as guide cell differentiation
and function. Furthermore, key criteria include biocompatibility and biodegradability, with
nontoxic and noninflammatory degradation products during replacement in vivo by cel-
lular ECM components.22 Many natural and synthetic polymers have been considered for
biomaterialscaffolds;however,thechallengingcombinationofbiocompatibility,biodegrad-
ability, controllable porosity, stability for an extended time-period during neotissue growth,
and processibility into porous matrixes often limit the utility of most polymers.23
A number of studies have demonstrated that upon sericin removal, regenerated SF has
good biocompatibility,18,24–26 heamocompatibility,27 oxygen and water permeability7,28 as
well as minimal inflammatory reaction. Separate studies have found that regenerated SF
filmspreparedbydissolvingsilkwormcocoonfibersin9–9.5Mlithiumbromidesupported
the attachment and proliferation of both human and animal cell lines.29,30
Collectively, these studies have recognized that SF offers versatility in biomaterial
scaffold/matrix design for use in tissue regeneration of bone, cartilage, blood vessels, liga-
ments,andtendons,inwhichmechanicalperformanceandbiologicalinteractionsaremajor
factors for success. Furthermore, for ease of utility, SF can be processed into films, fibers,
hydrogels, and meshes as shown by Min et al in 2004.21 A large number of fabrication tech-
niqueshavebeenappliedtoprocess3-dimensionalpolymericscaffoldsofhighporosityand
surface area. These include electrospinning, solvent casting/particulate leaching, emulsion
freeze-drying, thermally induced phase separation, and gas foaming.
NONWOVEN SF NANO-/MICROFIBROUS MEMBRANES
Recently, nonwoven SF membranes fabricated by electrospinning have gained attention
due to the ability to produce polymer nanofibers with diameters in the range of several
micrometers down to tens of nanometers.21 Researchers have investigated the effects of
442CASSANDRA SOBAJO ET AL
Figure 4. Structural components of silk.
nonwovenSFmicrofibrousnetsonthecultureofawidevarietyofhumancelllinesincluding
osteoblasts, fibroblasts, keratinocytes, and endothelial cells. These studies have shown that
these microfibrous nets support the adhesion, proliferation, and cell-cell interactions.31 In
addition, nonwoven SF nanofibrous mats were also found to support attachment, spreading
and proliferation of human bone marrow stromal cells, keratinocytes, and fibroblasts in
vitro.21,22
The biocompatibility of nonwoven microfibrous membranes has been shown to be
composed of partially dissolved native SF fibers.32 There were no infiltration of the lym-
pocytes present in the tissue even after 6 months of subcutaneous implantation, which
indicates a good biocompatibility. In addition, the implanted SF membranes were inte-
grated with the surrounding tissue within 6 months and no obvious degradation observed.
Previous in vivo studies have demonstrated SF-based membranes as promising materials
for skin regeneration.25,32
SF-BASED SCAFFOLDS AND STEM CELL-BASED TE
When considering stem cell-based TE, a reliable cell source that responds appropriately
in terms of morphology, proliferation, and tissue-specific differentiation to the biomate-
rial scaffold is of paramount importance. Although embryonic stem cells are capable of
differentiating into cell types of all different tissue lineages, a lack of understanding and
control of differentiation, as well as ethical and legal boundaries, limit their use in TE. In
contrast, adult stem cells with limited differentiation ability are an appealing alternative.
Mesenchymal stem cells are one such example, which can be isolated from various adult
tissue including adipose tissue,33 articular cartilage,34 bone marrow,35,36 and synovium.37
Mesenchymal stem cells and SF-based scaffolds have been extensively studied in ligament,
cartilage, and bone. However, there are currently limited published reports on their use in
skin, providing an area if interesting for further research.
DISCUSSION
Human skin is considered as one of the most important organs of the body, providing
a multitude of structural and functional benefits, ensuring perfect homeostasis.38 Since
tissue loss at the skin level is a common occurrence due to a multitude of events such
as lacerations, cutaneous disease, neoplasia, infection, burns and other trauma, adequate
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cutaneous constructs that could act as effective skin replacements, capable of mimicking
native skin are highly desirable.39
There are currently 2 different types of commercially available bilayered cutaneous
constructs.40 However, they are at present unable to fulfill all the structural and func-
tional properties of native skin; thus, the scope for engineering a novel cutaneous construct
remains.41 The development of innovative skin replacements has previously been along the
3approachesofTE,althoughthescaffoldapproachcommonlycreatedfromeithermodified
collagens or resorbable polymers is most frequently used.42
In vitro investigation has shown that several types of human cell lines, including der-
mal fibroblasts, epidermal keratinocytes, and endothelial cells, can be successfully cultured
on SF scaffolds in various forms; therefore, cell attachment, proliferation, and differentia-
tion can be studied accordingly.21,22 In addition, after in vivo implantation subcutaneously,
the SF implants were shown to integrate well with the surrounding tissue while no host
immunologic response was reported.25,32 Hence, the suitability of SF as a novel type of
biomaterial scaffold to be used for TE has been clearly demonstrated.
This encouraging breakthrough was attributed to the innovative characteristics of SF,
which includes the following:
 Good interaction with human cells in vitro that support cell-specific needs.21,22
 Compatibility in vivo following implantation without evoking a foreign body response
and therefore being capable of fully integrating into the surrounding host tissue.25,32
 It can be processed into aqueous solutions for subsequent formation of films as well as
other material formats.21
 Degradability at a controlled rate both in vitro and in vivo, which is of particular im-
portance with regards to biodegradable scaffolds where slow neotissue growth is most
desirable.18
SF also has novel mechanical properties that are capable of rivaling many natural or
synthetic high-performance fibers.13–18 Consequently, SF has been established as a highly
promising biomaterial for its surface morphology, superior structural and mechanical prop-
erties, in association with good biocompatibility and biodegradability, thus proving to be
a suitable scaffold for TE applications and subsequent development of novel cutaneous
constructs.
CONCLUSIONS
Tissue-engineered skin has advanced from the initial cultured autologous epidermal sheets
to more complex bilayered cutaneous constructs capable of mimicking selective structures
and functions of native skin. Silk fibroin, 1 of 2 proteins found in naturally occurring silk,
has been gaining momentum as a promising material for biomedical application due to its
abilitytobebiocompatiblewiththehostimmunesystem,aswellassupportcellattachment,
proliferation, and differentiation, which are key components for TE. Consequently, the
potential advantages of SF as a biomaterial scaffold are substantial, with the provision of
further possibilities in cell culture and TE, implying that adequate cutaneous constructs are
a realistic prospect in the not too distant future.
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